sufentanil has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherkalin, D; Koushik, SS; Sankar, V; Schwartz, RH; Shaparin, N; Viswanath, O | 1 |
| Bastos, FI; Bianchi, LM; Carvalho, RM; da Cunha, AJLA; de Magalhães-Barbosa, MC; Prata-Barbosa, A; Rodrigues-Santos, G | 1 |
1 review(s) available for sufentanil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures.
Topics: Analgesics, Opioid; COVID-19; Humans; Pain, Postoperative; SARS-CoV-2; Sufentanil; Tablets | 2022 |
1 other study(ies) available for sufentanil and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Shift in hospital opioid use during the COVID-19 pandemic in Brazil: a time-series analysis of one million prescriptions.
Topics: Adult; Analgesics, Opioid; Brazil; COVID-19; Fentanyl; Humans; Methadone; Morphine; Opioid-Related Disorders; Pandemics; Prescriptions; Remifentanil; Sufentanil; Tramadol | 2023 |